Abstract:Policy Points Reflecting on current response deficiencies, we offer a model for a national contingency supply chain cell (NCSCC) construct to manage the medical materials supply chain in support of emergencies, such as COVID-19. We develop the following: a framework for governance and response to enable a globally independent supply chain; a flexible structure to accommodate the requirements of state and county health systems for receiving and distributing materials; and a national material "control tower" to improve transparency and real-time access to material status and location. Context: Much of the discussion about the failure of the COVID-19 supply chain has centered on personal protective equipment (PPE) and the degree of vulnerability of care. Prior research on supply chain risks have focused on mitigating the risk of disruptions of specific purchased materials within a bounded region or on the shifting status of cross-border export restrictions. But COVID-19 has impacted every purchase category, region, and border. This paper is responsive to the National Academies of Sciences, Engineering and Medicine recommendation to study and monitor disasters and to provide governments with course of action to satisfy legislative mandates. Methods: Our analysis draws on our observations of the responses to COVID-19 in regard to acquisition and contracting problem-solving, our review of field discussions and interactions with experts, a critique of existing proposals for managing the strategic national stockpile in the United States a mapping of the responses to national contingency planning phases, and the identification of gaps in current national healthcare response policy frameworks and proposals. Findings: Current proposals call for augmenting a system that has failed to deliver the needed response to COVID-19. These proposals do not address the key attributes for pandemic plan renewal: flexibility, traceability and transparency, persistence and responsiveness, global independence, and equitable access. We offer a commons-based framework for achieving the opportunities and risks which are responsive to a constellation of intelligence assets working in and across focal targets of global supply chain risk. Conclusions: The United States needs a "commons-based strategy" that is not simply a stockpile repository but instead is a network of repositories, fluid inventories, and analytic monitoring governed by the experts. We need a coordinated effort, a "commons" that will direct both conventional and new suppliers to meet demands and to eliminate hoarding and other behaviors.

How Should Resources From National Stockpiles Be Managed?

A Commons for a Supply Chain in the Post-COVID-19 Era: The Case for a Reformed Strategic National Stockpile

A New Acquisition Model for the Next Disaster: Overcoming Disaster Federalism Issues Through Effective Utilization of the Strategic National Stockpile

The challenge of measuring emergency preparedness: integrating component metrics to build system-level measures for strategic national stockpile operations

Building the strategic national stockpile through the NIAID Radiation Nuclear Countermeasures Program

Scarcity in the Covid-19 Pandemic

At the Epicenter of COVID-19-the Tragic Failure of the Global Supply Chain for Medical Supplies

How Should We Draw on Pharmacists' Expertise to Manage Drug Shortages in Hospitals?

Society for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortages

A Novel Common Canister Protocol for Albuterol Sulfate Metered Dose Inhalers: Conservation Strategy and Clinical Outcomes Amid COVID-19 Pandemic

Optimizing Scarce Resource Allocation During COVID-19: Rapid Creation of a Regional Health-Care Coalition and Triage Teams in San Diego County, California

Pandemic risk management: Resources contingency planning and allocation

Hospital COVID-19 preparedness: Are (were) we ready?

Challenges to the System of Reserve Medical Supplies for Public Health Emergencies: Reflections on the Outbreak of the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Epidemic in China.

Vaccine Supply Chain Distribution under Covid-19 Pandemic:Stressed, Resourceful and Resilient- Lesson Learned from the United States Experiences

Multi-mitigation strategies in medical supplies for epidemic outbreaks

Nonconventional Ventilators During the COVID-19 Pandemic: Clinical Efficacy, Crisis Research Considerations, and Preparedness Next Steps*

Contributing factors to personal protective equipment shortages during the COVID-19 pandemic

Integrating Government Silos: Local Emergency Management and Public Health Department Collaboration for Emergency Planning and Response

Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges